Velocity’s cardiology research site in Lincoln partners with Pioneer Heart Institute to conduct clinical trials for drugs, medical devices, and diagnostics intended to help assess and treat cardiovascular disorders and conditions. Typical studies at this site involve medications or medical devices intended to help assess and treat cardiovascular disorders, such as heart disease, hypertension, stroke, hyperlipidemia, and more. Acquired by Velocity in 2022, the Lincoln location was founded in 2021 as part of Meridian Clinical Research.
Through the partnership with Pioneer Heart, the site is easily accessible to thousands of patients, including those established with the practice. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. Our Lincoln team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.